164 phd-in-mathematical-modelling-population Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
Metabolism (OCDEM) on studies related to circadian rhythms in population health. This post is part of a large, interdisciplinary research programme, offering attractive opportunities to work across
-
new understanding to bridge the gap between existing models for well-established hard and soft semiconductors. The resulting discoveries will provide a blueprint for light-harvesting materials, guiding
-
lowland river chemistry. Ultimately, these experiments will be used to parameterise calcite precipitation rate equations and empirical rate constants to inform catchment-scale modelling of ERW practices and
-
projects with colleagues in partner institutions, and research groups. You must hold a PhD/DPhil (or near completion). You will have extensive experience in live imaging of the spleen using 2-photon
-
of the Barron Group, including those conducting research in humans, including patient populations. The post holder will be part of the Barron Group based at the MRC BNDU and OxCIN. The Group has a strong track
-
determined by the funding available. About you You should hold, or be near completion of, a PhD/DPhil in Molecular Microbiology, Biochemistry, Biophysics or related discipline. You must have substantive
-
data to build hypothesis and test them in laboratory models. You will contribute ideas for new research projects, collaborate in the preparation of scientific reports and journal articles and act as a
-
Prof. Luigi Rizzi (Collège de France), seeks to investigate the acquisition of French from a cartographic perspective, employing the Growing Trees model developed by Friedmann, Belletti, and Rizzi, and
-
screening (XChem), PDB deposition and biophysical techniques including SPR, DSF and NMR. Applicants must hold a PhD in Biochemistry/ Biophysics / Chemical Crystallography or a related field (or have submitted
-
with cutting-edge models and technologies—including patient-derived glioblastoma organoids, CRISPR-based screens, mass cytometry, and advanced microscopy—to dissect these complex biological processes